Development of angiotensin II-induced abdominal aortic aneurysms is independent of Catalase in mice

Journal of Cardiovascular Pharmacology

Volumn 58, Issue 6, 2011, Pages 633-638

  Uchida, Haruhito A ^a   Sugiyama, Hitoshi ^a   Takiue, Keiichi ^a   Kikumoto, Yoko ^a   Inoue, Tatsuyuki ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

aneurysms; angiotensin II; catalase

Indexed keywords

4 HYDROXYNONENAL; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CATALASE; CHOLESTEROL; ELASTIN;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; BODY WEIGHT; CATALASE DEFICIENCY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYSTOLIC BLOOD PRESSURE;

ALDEHYDES; ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; BLOOD PRESSURE; BODY WEIGHT; CATALASE; CHOLESTEROL; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; OXIDATIVE STRESS;

EID: 83155161031     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182317196     Document Type: Article

References (43)

1. Thompson RW. Detection and management of small aortic aneurysms. N Engl J Med. 2002;346:1484-1486. (Pubitemid 34755718)
2. Baxter BT, Terrin MC, Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation. 2008;117:1883-1889. (Pubitemid 351507477)
3. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577-1589. (Pubitemid 40615407)
4. Henderson EL, Geng YJ, Sukhova GK, et al. Death of smooth muscle cells and expression of mediators of apoptosis by t lymphocytes in human abdominal aortic aneurysms. Circulation. 1999;99:96-104. (Pubitemid 29035963)
5. Miller FJ Jr, Sharp WJ, Fang X, et al. Oxidative stress in human abdominal aortic aneurysms: A potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol. 2002;22:560-565. (Pubitemid 34408734)
6. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part i: Basic mechanisms and in vivo monitoring of ROS. Circulation. 2003;108:1912-1916. (Pubitemid 37296532)
7. McCormick ML, Gavrila D, Weintraub NL. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2007;27:461-469.
8. Daugherty A, Manning MW, Cassis LA. Angiotensin ii promotes atherosclerotic lesions and aneurysms in apolipoprotein e-deficient mice. J Clin Invest. 2000;105:1605-1612. (Pubitemid 30390311)
9. Daugherty A, Cassis L. Chronic angiotensin ii infusion promotes atherogenesis in low density lipoprotein receptor -/- mice. Ann N Y Acad Sci. 1999;892:108-118.
10. Deng GG, Martin-McNulty B, Sukovich DA, et al. Urokinase-type plasminogen activator plays a critical role in angiotensin ii-induced abdominal aortic aneurysm. Circ Res. 2003;92:510-517. (Pubitemid 36368663)
11. Daugherty A, Manning MW, Cassis LA. Antagonism of at2 receptors augments angiotensin ii-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol. 2001;134:865-870. (Pubitemid 33016158)
12. Cassis LA, Rateri DL, Lu H, et al. Bone marrow transplantation reveals that recipient at1a receptors are required to initiate angiotensin ii-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol. 2007;27: 380-386. (Pubitemid 46143055)
13. Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein e/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001;104:448-454. (Pubitemid 32678276)
14. Satoh K, Nigro P, Matoba T, et al. Cyclophilin a enhances vascular oxidative stress and the development of angiotensin ii-induced aortic aneurysms. Nat Med. 2009;15:649-656.
15. Gavrila D, Li WG, McCormick ML, et al. Vitamin e inhibits abdominal aortic aneurysm formation in angiotensin ii-infused apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol. 2005;25: 1671-1677. (Pubitemid 41098939)
16. Thomas M, Gavrila D, McCormick ML, et al. Deletion of p47phox attenuates angiotensin ii-induced abdominal aortic aneurysm formation in apolipoprotein e-deficient mice. Circulation. 2006;114:404-413. (Pubitemid 44264822)
17. Wang M, Lee E, Song W, et al. Microsomal prostaglandin e synthase-1 deletion suppresses oxidative stress and angiotensin ii-induced abdominal aortic aneurysm formation. Circulation. 2008;117:1302-1309. (Pubitemid 351365673)
18. Jiang F, Jones GT, Dusting GJ. Failure of antioxidants to protect against angiotensin ii-induced aortic rupture in aged apolipoprotein(e)-deficient mice. Br J Pharmacol. 2007;152:880-890. (Pubitemid 350100492)
19. Sunami R, Sugiyama H, Wang DH, et al. Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2004;286: F1030-F1038. (Pubitemid 38656356)
20. Kobayashi M, Sugiyama H, Wang DH, et al. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int. 2005;68:1018-1031. (Pubitemid 43246418)
21. Sugiyama H, Kobayashi M, Wang DH, et al. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol Dial Transplant. 2005;20:2670-2680. (Pubitemid 41672265)
22. Fukuoka N, Sugiyama H, Inoue T, et al. Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice. Am J Nephrol. 2008;28:661-668. (Pubitemid 351832454)
23. Kikumoto Y, Sugiyama H, Inoue T, et al. Sensitization to alloxaninduced diabetes and pancreatic cell apoptosis in acatalasemic mice. Biochim Biophys Acta. 2010;1802:240-246.
24. Grigoryants V, Hannawa KK, Pearce CG, et al. Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. J Vasc Surg. 2005;41:108-114. (Pubitemid 40197505)
25. Feinstein RN, Howard JB, Braun JT, et al. Acatalasemic and hypocatalasemic mouse mutants. Genetics. 1966;53:923-933.
26. Feinstein RN, Suter H, Jaroslow BN. Blood catalase polymorphism: some immunological aspects. Science. 1968;159:638-640.
27. Wang DH, Masuoka N, Kira S. Animal model for oxidative stress research-catalase mutant mice. Environ Health Prev Med. 2003;8:37-40. (Pubitemid 36693031)
28. Odajima N, Betsuyaku T, Nagai K, et al. The role of catalase in pulmonary fibrosis. Respir Res. 2010;11:183.
29. Uchida HA, Kristo F, Rateri DL, et al. Total lymphocyte deficiency attenuates angii-induced atherosclerosis in males but not abdominal aortic aneurysms in apoe deficient mice. Atherosclerosis. 2010;211: 399-403.
30. Hashimoto N, Maeshima Y, Satoh M, et al. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am J Physiol Renal Physiol. 2004;286:F516-F525. (Pubitemid 38233646)
31. King VL, Lin AY, Kristo F, et al. Interferon-gamma and the interferoninducible chemokine cxcl10 protect against aneurysm formation and rupture. Circulation. 2009;119:426-435.
32. Subramanian V, Golledge J, Ijaz T, et al. Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with ppar{gamma}. Circ Res. 2010;107:953-958.
33. Lu H, Rateri DL, Cassis LA, et al. The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr Hypertens Rep. 2008;10: 99-106.
34. Silva J, Pastorello M, Arzola J, et al. At receptor and nad(p)h oxidase mediate angiotensin ii-stimulated antioxidant enzymes and mitogenactivated protein kinase activity in the rat hypothalamus. J Renin Angiotensin Aldosterone Syst. 2010;11:234-242.
35. Chou DS, Hsiao G, Shen MY, et al. ESR spin trapping of a carboncentered free radical from agonist-stimulated human platelets. Free Radic Biol Med. 2005;39:237-248. (Pubitemid 40814549)
36. Kakishita M, Nakamura K, Asanuma M, et al. Direct evidence for increased hydroxyl radicals in angiotensin ii-induced cardiac hypertrophy through angiotensin ii type 1a receptor. J Cardiovasc Pharmacol. 2003; 42(suppl 1):S67-S70. (Pubitemid 37467079)
37. Bagi Z, Erdei N, Koller A. High intraluminal pressure via h2o2 upregulates arteriolar constrictions to angiotensin ii by increasing the functional availability of at1 receptors. Am J Physiol Heart Circ Physiol. 2008;295: H835-H841.
38. Godin N, Liu F, Lau GJ, et al. Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice. Kidney Int. 2010;77:1086-1097.
39. Chen Y, Pearlman A, Luo Z, et al. Hydrogen peroxide mediates a transient vasorelaxation with tempol during oxidative stress. Am J Physiol Heart Circ Physiol. 2007;293:H2085-H2092. (Pubitemid 47605845)
40. Babamusta F, Rateri DL, Moorleghen JJ, et al. Angiotensin ii infusion induces site-specific intra-laminar hemorrhage in macrophage colonystimulating factor-deficient mice. Atherosclerosis. 2006;186:282-290.
41. Potier M, Karl M, Elliot SJ, et al. Response to sex hormones differs in atherosclerosis-susceptible and -resistant mice. Am J Physiol Endocrinol Metab. 2003;285:E1237-E1245. (Pubitemid 37464374)
42. Henriques T, Zhang X, Yiannikouris FB, et al. Androgen increases at1a receptor expression in abdominal aortas to promote angiotensin ii-induced AAAs in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol. 2008;28:1251-1256.
43. Rateri DL, Moorleghen JJ, Balakrishnan A, et al. Endothelial cellspecific deficiency of ang ii type 1a receptors attenuates ang ii-induced ascending aortic aneurysms in ldl receptor-/- mice. Circ Res. 2011;108: 574-581.